Eleven raises $10M in series A extension

Eleven Biotherapeutics Inc. (Cambridge, Mass.) raised $10 million in an extension of a series A round, bringing the total raised in the round to $45 million. New investor JAFCO joined existing investors Third Rock Ventures and Flagship Ventures. The company raised $35 million in the first closing in February 2010. JAFCO's Kenji Harada will join the company's board. ...